PCN29 Time to Next Treatment As a Candidate Surrogate Endpoint for Overall Survival in Previously Untreated Advanced Melanoma Patients Treated with Immune-Checkpoint Inhibitors
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.166
https://www.valueinhealthjournal.com/article/S1098-3015(20)32422-0/fulltext
Title :
PCN29 Time to Next Treatment As a Candidate Surrogate Endpoint for Overall Survival in Previously Untreated Advanced Melanoma Patients Treated with Immune-Checkpoint Inhibitors
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32422-0&doi=10.1016/j.jval.2020.08.166
First page :
Section Title :
Open access? :
No
Section Order :
10125